BeOne Medicines AG
ONC
$275.28
-$7.44-2.63%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/19/2026
-
MarketBeat
3/16/2026
-
MarketBeat
3/14/2026
-
MarketBeat
3/14/2026
-
MarketBeat
3/10/2026
-
MarketBeat
3/9/2026
-
MarketBeat
3/8/2026
-
MarketBeat
3/4/2026
-
MarketBeat
Assessing BeOne Medicines (NasdaqGS:ONC) Valuation After Its Recent Rebrand And Share Price Weakness
3/3/2026
-
Simply Wall St
3/3/2026
-
Insider Monkey
3/3/2026
-
MarketBeat
3/2/2026
-
Market News Video
3/1/2026
-
Insider Monkey
2/28/2026
-
MarketBeat
2/28/2026
-
MarketBeat
2/27/2026
-
MarketBeat
2/27/2026
-
MarketBeat
2/27/2026
-
MarketBeat
2/27/2026
-
MarketBeat
2/26/2026
-
MarketBeat
2/26/2026
-
MarketBeat
2/26/2026
-
MarketBeat
2/26/2026
-
Business Wire
2/21/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
41 61 685 19 00
Address
94 Aeschengraben 27
Basel, 4051
Basel, 4051
Country
Year Founded
Business Description
Sector
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s...
more